Publication | Closed Access

Ratios of T-cell immune effectors and checkpoint molecules as prognostic biomarkers in diffuse large B-cell lymphoma: a population-based study

Lymphoid NeoplasiaPrognostic BiomarkersCancer ImmunosurveillanceMedicineImmunologyPathologyImmune SurveillanceAutoimmunityImmune Checkpoint InhibitorAdult T-cell Leukemia-lymphomaImmunotherapyOncologyTumor MicroenvironmentCheckpoint MoleculesT-cell Immune Effectors